You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0268 Acpa seropositivity and peripheral natural killer cells as predictive markers of clinical response to rituximab in rheumatoid arthritis patients

Alerts

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Rheumatoid arthritis - prognosis, predictors and outcome
AB0268 Acpa seropositivity and peripheral natural killer cells as predictive markers of clinical response to rituximab in rheumatoid arthritis patients
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address